Valuation: TransMedics Group, Inc.

Market Cap 3B 2.62B 2.48B 2.25B 4.2B 288B 4.23B 29.5B 11.41B 146B 11.29B 11.04B 468B P/E 2026 *
62.2x
P/E 2027 * 39.4x
Enterprise Value 2.96B 2.58B 2.44B 2.22B 4.15B 284B 4.17B 29.11B 11.26B 144B 11.14B 10.89B 462B EV / Sales 2026 *
4x
EV / Sales 2027 * 3.27x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day-1.03%
1 week+1.90%
Current month+2.11%
1 month-1.91%
3 months+18.36%
6 months-30.52%
Current year-28.76%
1 week 80.58
Extreme 80.585
90.67
1 month 79.23
Extreme 79.23
95.18
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 01/08/1998
Director of Finance/CFO 55 02/12/2024
Chief Operating Officer 43 02/02/2023
Director TitleAgeSince
Director/Board Member 57 01/08/1998
Chairman 81 01/01/2011
Director/Board Member 78 01/02/2016
Date Insider Type Main position Quantity % Market Cap. Importance
11/09/26 Buy

Director

1,336 0.0039%
17/08/26 Don

Chairman

-18,000 0.0528%
10/07/26 Free

Chief Financial Officer

43,399 0.1273%
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%+1.90%-27.67%+45.55% 3B
+1.53%+9.14%+39.29%+27.70% 243B
+1.99%+5.97%+10.14%-16.75% 149B
+0.33%+6.40%-11.56%+29.78% 135B
-0.82%+1.04%-55.79%-17.67% 63.11B
-1.15%+1.71%+17.35%+20.56% 50.87B
-0.48%-0.18%-19.36%-15.71% 49.1B
+1.72%+9.24%+23.37%+34.88% 44.08B
+2.65%+6.99%+41.50%+55.81% 42.22B
+7.10%+21.82%+143.07%+67.76% 37.02B
Average +0.60%+5.10%+16.04%+23.19% 81.77B
Weighted average by Cap. +0.29%+6.29%+17.02%+17.09%

Financials

2026 *2027 *
Net sales 742M 646M 611M 556M 1.04B 71.03B 1.04B 7.28B 2.82B 36.1B 2.79B 2.72B 116B 875M 762M 721M 655M 1.22B 83.77B 1.23B 8.59B 3.32B 42.58B 3.29B 3.21B 136B
Net income 51.99M 45.28M 42.86M 38.94M 72.74M 4.98B 73.1M 510M 197M 2.53B 195M 191M 8.1B 89.08M 77.59M 73.43M 66.72M 125M 8.53B 125M 875M 338M 4.34B 335M 327M 13.88B
Net Debt -40.26M -35.07M -33.19M -30.15M -56.33M -3.86B -56.61M -395M -153M -1.96B -151M -148M -6.27B -146M -127M -120M -109M -204M -13.95B -205M -1.43B -553M -7.09B -547M -535M -22.69B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
17/09/26 $86.66 -1.03% 690,579
16/09/26 $87.56 -0.60% 464,754
15/09/26 $88.09 +2.60% 942,863
14/09/26 $85.86 +4.48% 943,381
11/09/26 $82.18 -3.36% 1,247,318
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
86.66USD
Average target price
97.30USD
Spread / Average Target
+12.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!